COMMUNIQUÉS West-GlobeNewswire

PositiveID CSO and Former DHS Chief Scientist Calls for “Nunn-Lugar Act 2.0” to Dismantle Unprecedented Chemical and Biological Weapons Stockpile in North Korea

05/06/2018 - 14:05

“Two Minutes to Doomsday” article views North Korea’s chemical and biological weapons as greater threat than nuclear DELRAY BEACH, Fla., June 05, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company [...]

Milestone Scientific Features CompuFlo® Epidural System at Euroanaesthesia 2018

05/06/2018 - 14:02

Multiple abstracts presented at scientific poster session LIVINGSTON, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a leading developer of computerized drug delivery instruments that [...]

Cognition Therapeutics Initiates NIA-Funded SNAP Study of Elayta™ to Measure Toxic Oligomer Displacement and Clearance in Alzheimer's Disease

05/06/2018 - 14:02

Pittsburgh, June 05, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]

Endocyte Announces Enrollment of First Patient in Phase 3 VISION Trial of 177Lu-PSMA-617 in Prostate Cancer

05/06/2018 - 14:01

Additional data from phase 2 investigator-initiated trial of 177Lu-PSMA-617 presented at American Society of Clinical Oncology (ASCO) WEST LAFAYETTE, Ind., June 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT [...]

Progressive Care Installs New TCGRx Pouch Packaging System in Miami

05/06/2018 - 14:00

Leading Florida-Based Healthcare Services and Technology Company Continues Expansion of Robot Pharmacy Machinery Fleet MIAMI, June 05, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized [...]

Spero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018

05/06/2018 - 14:00

Eighteen presentations with data across multiple pipeline candidates including data supporting SPR994’s broad spectrum of activity and equivalence to IV carbapenems CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- [...]

B-Temia to Showcase Keeogo at G7 Summit

05/06/2018 - 14:00

B-Temia / Keeogo invited to G7 Summit Innovation Experience QUÉBEC CITY, June 05, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotic tech company based in Quebec City and leader in the human mobility market is [...]

B-Temia présente le Keeogo au sommet du G7

05/06/2018 - 14:00

B-Temia / Keeogo est invité à l’Expérience Innovation du Sommet du G7 QUÉBEC, 05 juin 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., une entreprise canadienne de technologie biorobotique basée à Québec et leader sur le marché [...]

Caladrius Biosciences Sells Rights to Counter-Flow Centrifugation System to Hitachi Chemical Advanced Therapeutics Solutions

05/06/2018 - 14:00

Sale of non-core asset brings $2.5 million in non-dilutive funding BASKING RIDGE, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage [...]

CareDx Promotes Living Donor Transplantation Through Employee Policy

05/06/2018 - 14:00

The progressive CareDx Living Donor Employee Recovery Policy announced at ATC BRISBANE, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, [...]

Nu-Med Plus Inc. applies for Innovative Patent on Reactive Tube Coating

05/06/2018 - 14:00

SALT LAKE CITY, June 05, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent [...]

UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance

05/06/2018 - 14:00

RA’ANANA, Israel, and NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, today [...]

VANC Bolsters Hema-Fer Market Presence with Amazon Canada Store Launch and Advertising Approvals

05/06/2018 - 14:00

VANC receives PAAB approval for Hema-Fer detail aid VANC receives ASC approval for and launches Hema-Fer website ( www.hemafer.ca ) VANC launches Amazon Canada online store VANCOUVER, British Columbia, June 05, 2018 ( [...]

CRISPR Therapeutics to Participate in Three June Conferences

05/06/2018 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]

Aphios Granted United States Patent for Improved Delivery of Targeted siRNA Using Nanotechnology

05/06/2018 - 14:00

WOBURN, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been granted United States Patent No. 9,981,238 entitled “Apparatus and Methods for Making Nanosomes Loaded with Nucleic [...]

Resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” held on June 05th, 2018

05/06/2018 - 13:34

Resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” held on June 05th, 2018 Report of the Board on results of operations in 2017. To take notice of the Report of the Board of the JSC “Olainfarm [...]

Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery

05/06/2018 - 13:30

NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]

TG Therapeutics, Inc. to Present at the Jefferies 2018 Global Healthcare Conference

05/06/2018 - 13:30

Presentation scheduled for Thursday, June 7, 2018 at 10:30am ET NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and [...]

Solon Eiendom ASA : Primary insider notification

05/06/2018 - 08:31

(Oslo, Norway, June 04, 2018) UFI AS has today bought 26 458 shares in Solon Eiendom ASA at a price of NOK 30.20 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]